ResearcherHarbin Medical UniversityActive in the last 2 years

Chang-peng Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6078-2474; OpenAlex author ID A5024196036. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmace… Co-author DOI 10.3390/pharmaceutics18070808 ↗
Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/pharmaceutics15102447 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Melissa L. Fishel · 2 shared papers, 2023–2026 · strength 0.54
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808 ↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447 ↗
Qingji Huo · 2 shared papers, 2023–2026 · strength 0.54
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808 ↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447 ↗
Kexin Li · 2 shared papers, 2023–2026 · strength 0.54
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808 ↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447 ↗
Hiroki Yokota · 2 shared papers, 2023–2026 · strength 0.54
- Paper Correction: Cui et al. Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreat… DOI 10.3390/pharmaceutics18070808 ↗
- Paper Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinom… DOI 10.3390/pharmaceutics15102447 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.